December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Shushan Hovsepyan: Join us for our next 5-minute Sarcoma Talk on OncoDaily!
Apr 26, 2024, 08:07

Shushan Hovsepyan: Join us for our next 5-minute Sarcoma Talk on OncoDaily!

Shushan Hovsepyan, shared a post on LinkedIn:

“Join us for our next 5-minute Sarcoma Talk on OncoDaily! In our latest episode I had a very productive and educational conversation with Leo Mascarenhas.

We discussed the importance of Sarcoma Program at Cedars-Sinai, the role of vinorelbine in treating rhabdomyosarcoma and more.

Mascarenhas also shared his journey with invaluable insights and advice for young oncologists. Stay tuned for new episodes coming soon, right here on OncoDaily.
Learn more.”

Source: Shushan Hovsepyan/LinkedIn

Dr. Shushan Hovsepyan is a pediatric oncologist and adjunct assistant professor at the Yerevan State Medical University. She earned her medical degree (M.D.) from the same university’s General Medicine faculty, where she was awarded the Nominal Student Scholarship. Currently, she is a clinical research coordinator at the Yeolyan Hematology and Oncology Center. She completed a clinical fellowship lasting over a year at the pediatric oncology unit of the National Institute of Cancer in Milan, Italy, with a primary focus on pediatric sarcomas and rare tumors. Additionally, she was a clinical observer at the pediatric oncology unit of St. Anna Children’s Research Hospital in Austria for six months. Furthermore, she held a research fellowship position at the European Organisation for Research and Treatment of Cancer in Brussels, Belgium. Dr. Hovsepyan also completed the Postgraduate Harvard Medical School‘s Effective Writing for Healthcare program, focusing on writing and reviewing medical-scientific manuscripts. Dr. Hovsepyan is a member of the POEM Training Committee and a graduate of the College of the European School of Oncology. She is a former co-chair of the SIOP Global Health Network Education and Training Working Group.